Personalization of Targeted Therapy in Advanced Thyroid Cancer

Although generally the prognosis of differentiated thyroid carcinoma (DTC) is good, approximately 5% of people are likely to develop metastases which fail to respond to radioactive iodine, and other traditional therapies, exhibiting a more aggressive behavior. Nowadays, therapy is chosen and impleme...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallahi, Poupak, Ferrari, Silvia Martina, Mazzi, Valeria, Vita, Roberto, Benvenga, Salvatore, Antonelli, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064559/
https://www.ncbi.nlm.nih.gov/pubmed/24955027
http://dx.doi.org/10.2174/1389202915999140404101902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064559/
https://www.ncbi.nlm.nih.gov/pubmed/24955027
http://dx.doi.org/10.2174/1389202915999140404101902

Ejemplares similares